SCHEMBL19616169

SCHEMBL19616169

CC(NC(=O)c1ccc([N+](=O)[O-])cc1)c1cccc(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ NPC1 O15118 2/20 0.51
▸ TP53 P04637 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ MAPK1 P28482 5/20 0.50
▸ MAPK3 P27361 2/20 0.50
▸ MAPT P10636 3/20 0.49
▸ POLB P06746 2/20 0.49
▸ TRPA1 O75762 2/20 0.47
▸ CA2 P00918 1/20 0.47
▸ ALOX5 P09917 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ USP2 O75604 1/20 0.46
▸ LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28033626 0.85 POLB (0.47) SMN1; SMN2NPC1TP53RAB9AALDH1A1
SCHEMBL20474750 0.84 TRPA1 (0.57) HTTSMN1; SMN2NPC1TP53RAB9A
SCHEMBL20474748 0.84 TRPA1 (0.57) HTTSMN1; SMN2NPC1TP53RAB9A
SCHEMBL18610495 0.84 TRPA1 (0.57) HTTSMN1; SMN2NPC1TP53RAB9A
SCHEMBL10763104 0.84 NPC1 (0.65) HTTSMN1; SMN2NPC1TP53RAB9A
SCHEMBL10768107 0.84 NPC1 (0.65) HTTSMN1; SMN2NPC1TP53RAB9A
SCHEMBL10763115 0.84 NPC1 (0.65) HTTSMN1; SMN2NPC1TP53RAB9A
SCHEMBL15663909 0.82 ALDH1A1 (0.51) SMN1; SMN2TP53ALDH1A1MAPK1MAPT
SCHEMBL28408095 0.81 LMNA (0.47) SMN1; SMN2ALDH1A1MAPTPOLBCYP3A4
Dinitrophenylene SCHEMBL27967039 0.78 ALDH1A1 (0.59) HTTSMN1; SMN2NPC1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017199103-A1 BENZAMIDE COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2017-11-23 — — WO disclosed
Send feedback